Companies

Nanogen was founded in 1993, to integrate advanced microelectronics and molecular biology into a core technology platform with potentially broad and diverse commercial applications. Shares in Nanogen began trading on the NASDAQ following an IPO in 1998. The company began selling its first two products in the second quarter of 2000. Nanogen's advanced diagnostics provide researchers, healthcare professionals and patients worldwide with improved methods and tests to investigate, predict, diagnose and ultimately help treat disease. They are utilizing their portfolio of markers and technologies to promote research in and the development of products that will enable diagnostics to provide proactive versus reactive healthcare. Nanogen's strategy is to assemble companies, products and technologies necessary to become a leader in advanced diagnostics.